China Life commits up to 4.5 billion yuan to AI and semiconductor equity fund
China Life Insurance Company announced on September 24 that its board approved contributing up to 4.5 billion yuan as a limited partner in the Qingdao Chengxin Zhida Equity Investment Center, a partnership with total capital not exceeding 6 billion yuan. The fund will invest in unlisted equity in artificial intelligence and semiconductor sectors. The partnership agreement is expected to be signed by December 31, 2026.
IllustrationEditorial responsibility
- No named human review is recorded for this page.
- Reports are grouped by semantic similarity and deterministic rules. Language models may assist titles, summaries, translation and cross-source analysis; the page reads the event directly, while its address stays stable when the title changes.
- Summary awaiting refresh
Summary awaiting refresh
Cross-source coverage
Reporting timeline
China Life to invest up to 4.5 billion yuan in AI and semiconductor fund
China Life Insurance Company (601628) announced on September 24 that it plans to establish a partnership, Qingdao Chengxin Zhida Equity Investment Center (Limited Partnership), with Wuxi Guoshou Chengda Equity Investment Center and other investors. The partnership's total capital contribution will not exceed 6 billion yuan, with China Life contributing up to 4.5 billion yuan as a limited partner. Guoshou Chengda (Shanghai) Health Medical Equity Investment Management Co., Ltd. will serve as the general partner. The partnership will focus on investing in high-quality unlisted equity in the artificial intelligence and semiconductor sectors. The announcement was reported by People's Financial News and Securities Times.
Read sourceChina Life Insurance Board Approves Up to 4.5 Billion Yuan Investment in Partnership
China Life Insurance Company announced on September 24 that its board of directors has approved the establishment of a limited partnership, Qingdao Chengxin Zhida Equity Investment Center, with related parties and other investors. The total proposed capital contributions from all partners will not exceed 6 billion yuan, with China Life committing up to 4.5 billion yuan. The board reviewed and passed the relevant resolution on September 24, 2026, and the company expects to sign the partnership agreement and ancillary agreements by December 31, 2026. The announcement was sourced from TradeAlpha, a domestic financial news outlet.
China Life Insurance Board Approves Up to 4.5 Billion Yuan Investment in Partnership
China Life Insurance Company announced on September 24 that its board of directors has approved a plan to participate in the establishment of a new limited partnership, Qingdao Chengxin Zhida Equity Investment Center (Limited Partnership). The total proposed capital contribution from all partners will not exceed 6 billion yuan (approximately $850 million USD). China Life itself plans to contribute up to 4.5 billion yuan. The board approved the relevant resolution on September 24, 2026, and the partnership agreement and ancillary agreements are expected to be signed by December 31, 2026. The announcement was made via a filing to the Shanghai Stock Exchange and reported by financial data provider Jin10. The move is part of China Life's investment strategy, leveraging partnerships to deploy capital in equity investments.
Read sourceShow 3 older updatesHide older updates
China Life to invest up to 4.5 billion yuan in AI and semiconductor fund
China Life Insurance Company announced on September 24 that it plans to invest up to 4.5 billion yuan (approximately $620 million) as a limited partner in a new private equity fund, the Qingdao Chengxin Zhida Equity Investment Center. The total capital commitment from all partners will not exceed 6 billion yuan. The fund will focus on investing in high-quality pre-IPO equity in the artificial intelligence and semiconductor sectors. The move signals China Life's strategic allocation into cutting-edge technology areas, aligning with national industrial policy priorities. The announcement was made via a stock exchange filing and reported by financial media outlet Cailianshe.
Read sourceChina Life to Invest Up to 4.5 Billion Yuan in AI and Semiconductor Fund
China Life Insurance Company (601628) announced on September 24 that it plans to invest up to 4.5 billion yuan (approximately $630 million) to establish a new investment partnership. The partnership, tentatively named Qingdao Chengxin Zhida Equity Investment Center, will have a total proposed capital of up to 6 billion yuan. China Life will act as a limited partner alongside Wuxi China Life Chengda Equity Investment Center and other investors. The general partner will be China Life Chengda (Shanghai) Health Medical Equity Investment Management Co., Ltd. The partnership's primary focus will be investing in high-quality pre-IPO equity in the artificial intelligence and semiconductor sectors.
Read sourceChina Life Insurance Board Approves Up to 4.5 Billion Yuan Partnership Investment
China Life Insurance Company announced that its board of directors has approved a plan to co-establish a limited partnership, Qingdao Chengxin Zhida Equity Investment Center, with related parties and other investors. The total proposed capital contributions from all partners will not exceed 6 billion yuan, with China Life committing to contribute no more than 4.5 billion yuan. The board passed the relevant resolution on September 24, 2026, and the company expects to sign the partnership agreement and ancillary agreements by December 31, 2026. The announcement was made via a stock exchange filing and reported by Stockstar, a Chinese financial news outlet.
Read source